Biomarker investigations from the ATAC trial: the role of TA01

Tissue microarrays for high-throughput molecular profiling of tumor specimens

1998 • 4,104 citations

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial

2002 • 1,954 citations

Letrozole Is More Effective Neoadjuvant Endocrine Therapy Than Tamoxifen for ErbB-1– and/or ErbB-2–Positive, Estrogen Receptor–Positive Primary Breast Cancer: Evidence From a Phase III Randomized Trial

2001 • 1,075 citations

Overview of the main outcomes in breast-cancer prevention trials

2003 • 941 citations

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early‐stage breast cancer

2003 • 856 citations

Measurement of Gene Expression in Archival Paraffin-Embedded Tissues

2004 • 537 citations

Anastozole (A) is superior to tamoxifen (T) in treatment of postmenopausal (PM) women with early breast cancer (EBC) - First results of the ATAC (Arimidex, tamoxifen, alone or in combination) trial (on behalf of the ATAC Trialists' Group)

2002 • 246 citations

Quantitative analysis of breast cancer tissue microarrays shows that both high and normal levels of HER2 expression are associated with poor outcome.

2003 • 204 citations

Tissue microarrays in drug discovery

2003 • 198 citations

Estrogen receptor: current understanding of its activation and modulation.

2001 • 197 citations

Growth factor receptor cross-talk with estrogen receptor as a mechanism for tamoxifen resistance in breast cancer

2003 • 145 citations

Cross-talk among estrogen receptor, epidermal growth factor, and insulin-like growth factor signaling in breast cancer.

2001 • 140 citations

Serum HER-2/neu and Response to the Aromatase Inhibitor Letrozole Versus Tamoxifen

2003 • 127 citations

Dual role of oestrogens as hormones and pro-carcinogens: tumour initiation by metabolic activation of oestrogens

1997 • 119 citations

Inhibition of erbB receptor (HER) tyrosine kinases as a strategy to abrogate antiestrogen resistance in human breast cancer.

2001 • 93 citations

Tissue microarray study for classification of breast tumors

2003 • 45 citations

Tissue microarray analyses of G1/S-regulatory proteins in ductal carcinoma in situ of the breast indicate that low cyclin D1 is associated with local recurrence

2003 • 42 citations

Tissue Microarrays

2003 • 28 citations

Utilization of human tissue in breast cancer research

2000 • 13 citations

675 Anastrozole is an effective neoadjuvant therapy for patients with hormone-dependent, locally-advanced breast cancer irrespective of cerbB2 status

2003 • 10 citations